CLEO Diagnostics Affirms Corporate Governance Compliance

CLEO Diagnostics Ltd (AU:COV) has released an update.

CLEO Diagnostics Ltd has updated its corporate governance statement, which is now accessible on their website and reflects full compliance with the ASX Corporate Governance Council’s recommendations for the financial year ended 30 June 2024. The statement, approved by the board and current as of 27 August 2024, provides transparency on the company’s governance practices and adherence to established guidelines.

For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.